IOL Chemicals and Pharmaceuticals Limited (IOLCP) reported revenue of ₹756 Cr and net profit of ₹64.40 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
IOLCP fundamentals, Fundamental score 56/100
The statements below are read from IOL Chemicals and Pharmaceuticals Limited’s filed results, 17 filed quarters and 5 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Aug 11, 2026 · audited
Sales CAGR · 3Y+1.5%FY22 → FY25
Sales CAGR · 4Y+1.5%FY21 → FY25
PAT CAGR · 3Y−0.4%FY22 → FY25
PAT CAGR · 4Y−4.8%FY21 → FY25
Price · 1Y+103.6%EOD
Price CAGR · 3Y+29.2%EOD
Quarterly resultsConsolidated
₹ Cr
Jun2022
Sep2022
Dec2022
Mar2023
Jun2023
Sep2023
Dec2023
Mar2024
Jun2024
Sep2024
Dec2024
Mar2025
Jun2025
Sep2025
Dec2025
Mar2026
Jun2026Latest
YoYlatest
Sales
565
541
523
587
563
545
520
504
502
526
523
528
552
568
580
619
756
+37.1%
509
510
481
492
491
481
476
454
451
484
476
465
490
510
523
527
653
+33.3%
Operating profit
55.8
31.9
42.7
95.3
72.5
64.2
44.4
49.5
51.1
41.6
46.9
62.8
62.1
57.1
57.3
92.5
103
+66.5%
OPM %
9.9%
5.9%
8.2%
16.2%
12.9%
11.8%
8.5%
9.8%
10.2%
7.9%
9.0%
11.9%
11.3%
10.1%
9.9%
14.9%
13.7%
+2.4 pp
Other income
5.16
5.07
6.65
8.73
7.06
7.11
8.38
7.52
7.38
6.43
4.07
4.53
7.37
6.88
5.29
1.84
8.18
+11.0%
Interest
3.38
3.51
4.70
4.88
3.95
4.44
4.30
3.41
2.15
4.12
4.46
4.03
4.23
3.48
3.63
3.21
3.64
-13.9%
Depreciation
11.0
11.3
11.8
12.1
14.5
15.7
16.3
16.4
16.8
17.9
18.7
18.6
19.8
20.0
20.2
20.3
21.3
+7.9%
Profit before tax
46.6
22.1
32.9
87.0
61.2
51.2
32.1
37.2
39.5
25.9
27.8
44.7
45.5
40.5
27.6
70.8
86.7
+90.5%
Tax %
25.6%
28.1%
27.7%
25.6%
25.0%
26.0%
28.1%
25.8%
24.2%
26.2%
26.2%
29.7%
25.4%
26.0%
25.3%
24.9%
25.7%
+0.3 pp
Net profit
34.7
15.9
23.8
64.8
45.9
37.9
23.1
27.6
30.0
19.2
20.5
31.4
33.9
30.0
20.6
53.2
64.4
+89.8%
EPS (₹)
1.18
0.54
0.81
—
1.56
1.29
0.79
0.94
1.02
0.65
0.70
1.07
1.16
1.02
0.70
1.81
2.20
+89.7%
One column per filed quarter · ₹ crore · YoY = latest vs the same quarter a year back · EPS restated for bonus/split↔ scroll for earlier quarters
Revenue & net profit trend
last 17 quarters
RevenueNet profit
Revenue & net profit — Consolidated17 quarters
Segment results
Needs segment dataSegment results not parsedPer-segment revenue, EBIT margin and YoY arrive once we parse the segment annexure from the filing.
Forensic checksauto-scanned from the filing
Coming soonForensic checks not connectedAuditor opinion, OCF÷PAT, contingent liabilities, related-party share and working-capital days arrive as we parse the notes-to-accounts + cash-flow statement. Promoter-pledge is already on the Holdings tab.
How results moved the priceEOD reaction on the session the market could trade the filing
Avg absolute result-day move ±3.9%· EPS surprise: no estimates source
Q1'27filed Mon 10 Aug 14:15 · traded that sessiongap +0.6%close −1.9%
Q4'26filed Wed 20 May 14:31 · traded that sessiongap −1.0%close +8.6%
Q3'26filed Wed 11 Feb 17:10 · first tradeable session Thu 12 Febgap +0.6%close −0.9%
Q2'26filed Tue 11 Nov 15:37 · first tradeable session Wed 12 Novgap +5.0%close +10.9%
Q1'26filed Thu 7 Aug 14:30 · traded that sessiongap −1.6%close +3.0%
Q4'25filed Fri 16 May 19:06 · first tradeable session Mon 19 Maygap +1.5%close +1.4%
Q3'25filed Wed 12 Feb 18:05 · first tradeable session Thu 13 Febgap −1.2%close −1.4%
Q2'25filed Thu 14 Nov 17:00 · first tradeable session Mon 18 Novgap −2.1%close −6.1%
Q1'25filed Fri 9 Aug 18:37 · first tradeable session Mon 12 Auggap −1.4%close −0.9%
Q4'24filed Tue 14 May 16:59 · first tradeable session Wed 15 Maygap −1.8%close −2.9%
Q3'24filed Tue 6 Feb 18:15 · first tradeable session Wed 7 Febgap −7.3%close −5.6%
Q2'24filed Wed 8 Nov 16:06 · first tradeable session Thu 9 Novgap −0.1%close −4.6%
Q1'24filed Wed 9 Aug 18:05 · first tradeable session Thu 10 Auggap +1.0%close −1.6%
